Daniotti M, la Marca G, Fiorini P, Filippi L.New developments in the treatment of hyperammonemia: emerging use of carglumic acid. International Journal of General Medicine. 2011;4:21-28.
Star K, Edwards IR, Choonara I. Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase. PLoS One. 2014; 9:e108970.
Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity — what is the evidence? Crit Care. 2005;9:431-40.
Aires CC, Van Cruchten A, Ijlst L, de Almeida IT, Duran M, Wanders RJ, et al. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. J Hepatol. 2011; 55:426-34.
DOI: 10.1016/j.jhep.2010.11.031
Gramage Caro T, Vélez-Díaz-Pallarés M, Serna Pérez J, Bermejo Vicedo T. Carglumic acid for treatment of valproic acid-induced hyperammonaemia in a paediatric patient. Farm Hosp. 2012; 5:437.
DOI: 10.1016/j.farma.2011.08.005
Grynnerup A, Sanchez Fernandez I, Calzada Hernandez J, et al. A Severe Valproate Overdose With Complete Recovery in a Newborn. J Child Neurol. 2012; 27:1072-6.
DOI: 10.1177/0883073811431497
Weise S, Syrbe S, Preuss M, Bertsche A, Merkenschlager A, Bernhard MK. Pronounced reversible hyperammonemic encephalopathy associated with combined valproate–topiramate therapy in a 7-year-old girl. Springerplus. 2015; 4: 276.
DOI: 10.1186/s40064-015-1057-9
Vázquez M, Fagiolino P, Maldonado C, Olmos I, Ibarra M, Alvariza S, et al. Hyperammonemia Associated with Valproic Acid Concentrations. Biomed Res Int. 2014; 2014: 217269.
DOI: 10.1155/2014/217269
Pedron Giner C, Lopez Marin L, Quijada Fraile P, et al. Valproate induced hyperammonaemic encephalopathy syndrome. Treatment with carglumic acid . J Inherit Metab Dis. 2008; 31 Suppl 1:S89.
Chopra A, Prakash Kolla B, Mansukhani MP, Netzel P, Frye MA. Valproate induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry. 2012; 34:290–98
DOI: 10.1016/j.genhosppsych.2011.12.009
Noh Y, Kim DW, Chu K, St Lee, Jung KH, Moon JH et al. Topiramate increases the risk of valproic acid-induced encephalopathy. Epilepsia. 2013; 54:e1–e4.
Hamer HM, Knake S, Schomburg U, Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000; 54:230-32.
DOI: 10.1212/WNL.54.1.230
Gomez-Ibanez A, Urrestarazu-Bolumburu E, Viteri-Torres C Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism. Epilepsy Behav. 2011; 21:480-82.
Carlson T, Reynolds CA, Caplan R. Case report: valproic acid and risperidone treatment leading to development of hyperammonemia and mania. J Am Acad Child Adolesc Psychiatry. 2007; 46:356–61.
DOI: 10.1097/chi.0b013e31802ed8b2
Martín-Hernández E, Quijada-Fraile P; Oliveros-Leal L; García-Silva MT; Pérez-Cerdá C, et al. Nutritional and pharmacological management during chemotherapy in a patient with propionic acidaemia and rhabdomyosarcoma botryoides. JIMD Rep. 2012; 6:73-78.
DOI: 10.1007/8904_2012_137
Grupo de consenso. Protocolo hipano-luso de diagnóstico y tratamiento de las hiperamoniemias en pacientes neonatos y de más de 30 días de vida. 2 ed, Ergón, Madrid, 2009.
Alfadhel M, Middle East Hyperammonemia and Urea Cycle Disorders Scientific Group (MHUSG). Guidelines for acute management of hyperammonemia in the Middle East region. Therapeutics and Clinical Risk Management. 2016; 12: 479-487.
DOI: 10.2147/TCRM.S93144
Valayannopoulos V, Baruteau J, Bueno Delgado M, Cano A, Couce ML, Del Toro M, et al. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study. Orphanet Journal of Rare Diseases. 2016; 11:32.
DOI: 10.1186/s13023-016-0406-2
Filippi L, Gozzini E, Fiorini P, Malvagia S, la Marca G, Donati MA. N-Carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology. 2010; 97:286-90.
DOI: 10.1159/000255168
Gebhardt B, Dittrich S, Parbel S, Vlaho S, Matsika O, Bohles H. N-carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia. J Inherit Metab Dis. 2005; 28:241-44.
DOI: 10.1007/s10545-005-5260-7
Kasapkara CS1, Ezgu FS, Okur I, Tumer L, Biberoglu G, Hasanoglu A. N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia. Eur J Pediatr. 2011; 170:799-801.
DOI: 10.1007/s00431-010-1362-9
Fukada M, Kawabe M, Takehara M, Iwano S, Kuwabara K, Kikuchi C et al. Carnitine deficiency: risk factors and incidence in children with epilepsy. Brain. 2014; Dev.